Zusammenfassung
Nach Vorbehandlung mitl-HMD (peripherer Hemmer der Dopa-Dekarboxylase) wird mitl-Dopa (25 und 50 mg/kg i.v.) Blutdruck und Herzfrequenz herabgesetzt.
Literatur
G. C. Cotzias, P. S. Papavasiliou andR. Gellene, New Engl. J. Med.280, 337 (1969).
M. D. Yahr, R. C. Duvoisin, M. J. Schear, R. E. Barrett andM. M. Hoehn, Arch. Neurol.21, 343 (1969).
D. B. Calne, J. Brennan, A. S. D. Spiers andG. M. Stern, Br. med. J.1, 474 (1970).
R. Degkwitz, R. Frowein, C. Kulenkampff andU. Mohs, Klin. Wschr.38, 120 (1960).
P. Holtz andD. Palm, Ergebn. Physiol.58, 1 (1966).
J. M. Gaillard, P. Schaeppi andR. Tissot, Archs int. Pharmacodyn. Thér.180, 423 (1969).
J. Constantinidis, J. C. de la Torre, R. Tissot andF. Geissbühler, Psychopharmacologia15, 75 (1969).
A. Bertler, B. Falck, C. H. Owman andE. Rosengren, Pharmac. Rev.18, 369 (1966).
G. G. S. Collins andG. B. West, Br. J. Pharmac.34, 514 (1968).
M. Henning andA. Rubenson, J. Pharm. Pharmac.22, 241 (1970).
M. Henning andA. Rubenson, J. Pharm. Pharmac.22, 553 (1970).
C. C. Porter, L. S. Watson, D. C. Titus, J. A. Totaro andS. S. Byer, Biochem. Pharmac.11, 1067 (1962).
G. Bartholini andA. Pletscher, J. Pharm. Pharmac.21, 323 (1969).
V. J. Lotti andC. C. Porter, J. Pharmac. exp. Ther.172, 406 (1970).
G. Bartholini, W. P. Burkard andA. Pletscher, Nature, Lond.215, 852 (1967).
T. Svensson andB. Waldeck, Eur. J. Pharmac.7, 278 (1969).
V. G. Butuzov, Byull. exp. Biol. Med., USSR35, 65 (1970).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Minsker, D.H., Scriabine, A., Stokes, A.L. et al. Effects ofl-dopa alone and in combination with dopa decarboxylase inhibitors on the arterial pressure and heart rate of dogs. Experientia 27, 529–531 (1971). https://doi.org/10.1007/BF02147580
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02147580